<
 
 
 
 
×
>
You are viewing an archived web page captured at 22:25:57 Apr 19, 2022, which is part of the National Records of Scotland Web Archive. The information on this web page may be out of date. See all captures of this archived page. Archived web pages you visit here may leave cookies in your browser. These are not owned, controlled, or used by NRS. NRS do use cookies, including Google Analytics, to monitor site usage and performance. These can be managed in your browser settings. Find out more about cookies.
Loading media information
hide
Information

Coronavirus (COVID-19) AstraZeneca vaccine (ChAdOx1-S [Recombinant]): national protocol v2.4

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows supply and administration during or in anticipation of the COVID-19 pandemic.

This document is part of a collection


AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol

Reference no: AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine Protocol

Version no: v02.4

Valid from: 02 February 2021

Review date: 30 November 2021

Expiry date: 31 December 2021

Contact

Email: vaccineoperationaloversight@gov.scot

Back to top